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The enzyme arylmalonate decarboxylase (AMDase) enables the selective synthesis of
enantiopure (S)-arylpropinates in a simple single-step decarboxylation of dicarboxylic
acid precursors. However, the poor enzyme stability with a half-life time of
about 1.2 h under process conditions is a serious limitation of the productivity,
which results in a need for high catalyst loads. By immobilization on an amino
C2 acrylate carrier the operational stability of the (S)-selective AMDase variant
G74C/M159L/C188G/V43I/A125P/V156L was increased to a half-life of about 8.6 days,
which represents a 158-fold improvement. Further optimization was achieved by simple
immobilization of the cell lysate to eliminate the cost- and time intensive enzyme
purification step.
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INTRODUCTION
The integration of biocatalysis is nowadays well-established in chemical industry, especially in the
synthetic segments for stereo-, regio-, and enantioselective production of organic fine chemicals
and drugs (Schmid et al., 2002). Biocatalysis combines several desired characteristics for an efficient
conversion, such as high selectivity and environmentally friendly reaction conditions. However,
the implementation of enzymes bears some challenges, like the stability under process conditions
and separation of the soluble biocatalyst from the product after the process (Klibanov, 1983).
Reaction conditions in industrial applications of biocatalysts often differ from the natural enzyme
environment, which can lead to a fast enzyme inactivation. This drawback can be circumvented
either by molecular engineering methods, i.e., optimizing the enzyme structure to receive a more
stable biocatalyst (Bornscheuer et al., 2012), or by immobilization of the enzyme (Liese and
Hilterhaus, 2013).
Several immobilization methods are available and well-established: (i) Immobilization onto a
solid carrier material, (ii) enzyme affixed into a matrix with enzyme encapsulation/entrapment
strategies or (iii) enzyme immobilized via crosslinking (Hanefeld et al., 2009). In this study, we
focus on the immobilization of enzymes on solid carrier materials. The coupling of the enzyme
onto the carrier can be realized in a reversible or an irreversible manner. In the irreversible way,
the enzyme is coupled to the carrier by a specific covalent binding of amino acid side chains (lysine,
cysteine, aspartic or glutamic acids) via stable amide, thioether, or carbamate bonds to the carrier
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material (Mohamad et al., 2015). For the reversible coupling,
different methods are available. The most common ones are
achieved through unspecific adsorption by ionic or hydrophobic
interaction with the enzyme (Guisan, 2006), disulfide bond
formation with cysteine side chains (Simons et al., 2013) or
through complexation, e.g., with His6 affinity tagged proteins
(Engelmark Cassimjee et al., 2014). Beside the bonding type,
different carrier properties influence the enzyme immobilization.
Especially the carrier size, its porosity and surface properties have
a significant impact on the enzyme loading and activity yield
(Datta et al., 2013).
In this study, we demonstrate the advantage of enzyme
immobilization for an efficient synthesis of α-arylpropionate
derivatives. These so-called profenes, like ibuprofen or naproxen,
are widely used as non-steroidal anti-inflammatory drugs
(NSAID) (Rao and Knaus, 2008). The challenge in the synthesis
of this class of molecules is their chirality, since only the
(S)-enantiomers show the desired medical effects (Nguyen
et al., 2006). One enzyme capable of catalyzing the crucial
enantioselective synthetic step in a selective and environmentally
friendly manner is arylmalonate decarboxylase (AMDase, EC
4.1.1.76). AMDase originates from Bordetella bronchiseptica
and was discovered by Miyamoto and Ohta (1990). Since
then, this enzyme received significant attention owing to
its capability of a highly enantioselective arylpropionate
synthesis. The natural (R)-selective wild type enzyme could
successfully be designed into a (S)-selective mutant through the
exchange of crucial amino acids in the active site (Ijima et al.,
2005; Kourist et al., 2011). The (S)-selective AMDase variant
G74C/M159L/C188G/V43I/A125P/V156L (AMDase-CLGIPL)
shows an excellent (>99%) enantioselectivity in the production
of (S)-flurbiprofen (Gaßmeyer et al., 2016). Figure 1 illustrates
the general decarboxylation reaction of arylmalonates catalyzed
by the wild type or the AMDase mutant to the respective (R)
and (S)-arylpropionates, respectively. Unfortunately, AMDase
is known to be an unstable enzyme with a theoretical instability
index of about 43.20 (ExPASy ProtParam tool, Guruprsad et al.,
1990). Enzyme immobilization is the method of choice to tackle
the stability issues in order to develop a process for the efficient
biocatalytic synthesis of enantiopure arylpropionates and hence
is the focus of this study.
MATERIALS AND METHODS
Protein Expression and Purification
Recombinant Escherichia coli BL21 (DE3) containing an IPTG
(isopropyl-β-D-thiogalactopyranosid) inducible plasmid with
the gene for AMDase G74C/M159L/C188G/V43I/A125P/V156L
(AMDase-CLGIPL) (Gaßmeyer et al., 2016), was cultivated as
described in Gaßmeyer et al. (2016). After protein expression,
the cells were harvested by centrifugation (20 min, 4◦C, and
17,700 × g) and stored at −80◦C unless directly used. For
cell lysis, the cell pellet was resuspended to a concentration
of 0.2 gcells/mL in 50 mM Tris buffer pH 7.0 or in water
and ultrasonication was performed using a Sonoplus HD2070
sonicator (90% intensity, 3 × 3 min, and interjacent cooling on
FIGURE 1 | AMDase catalyzed asymmetric synthesis of
(R)-arylpropionates (wild type AMDase) and (S)-arylpropionates
(AMDase-CLGIPL). R can be arylic, aliphatic, halogen atoms and other
substituents.
ice). The cell lysate was separated by centrifugation from the
solid cell components (30 min, 4◦C, and 74,000 × g). The cell
lysate was either directly used or the histidine tagged AMDase
was purified over a Ni-NTA HisTrap IMAC (immobilized metal
ion affinity chromatography) column. For enzyme purification,
10 mM imidazole was added to the lysate. The resin was
equilibrated (50 mM Tris buffer, 10 mM imidazole, and pH 7.0),
afterward the lysate was loaded onto the purification column and
washed with five column volumes of washing buffer (50 mM Tris
buffer, 20 mM imidazole, and pH 7.0). The target enzyme was
eluted by increasing the imidazole concentration with elution
buffer (50 mM Tris buffer, 250 mM imidazole, and pH 7.0).
The collected enzyme fractions were desalted and concentrated
using an Amicon ultrafiltration cell equipped with a 10 kDa
membrane. The concentration of the obtained protein solution
was determined by Bradford Assay using the reported method
of Zor and Selinger (1996). Activity based protein analysis was
also done to determine the target protein concentration in the
cell lysate (Supplementary Figure S6).
Enzyme Immobilization
Carriers EziGTM 1, 2, and 3 were kindly provided from
Enginzyme (Stockholm, Sweden). Amino C2 acrylate carrier was
obtained from Iris Biotech GmbH (Marktredwitz, Germany),
Trisoperl carrier was purchased from Sigma Aldrich (Steinheim,
Germany), and Sepabeads carriers were obtained from Residion
S.r.l. (Binasco, Italy). Immobilization of wtAMDase or (S)-
selective AMDase-CLGIPL on different carrier materials for
screening of suitable solid supports was performed with freshly
purified enzyme or the cell lysate from freshly lysed cells,
respectively. In the case of the amine functionalized carrier, a
pre-activation with a 2% v/v glutaraldehyde solution was carried
out (212 mM, ratio 1:4 wcarrier/v, 250 mg/mL), 1 h, overhead
shaker, room temperature, 8 rpm), filtered with a sintered glass
filter (pore size 2, 40–100 µm) and then carefully washed with
distilled water. For immobilization, the different carrier materials
were incubated with the enzyme solution (40 mgcarrier/mL,
4–8 mgenzyme/mL) in 50 mM Tris buffer at pH 7.0 (for the first
screening experiment with wtAMDase) or in water with pH 8.0
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(starting with AMDase-CLGIPL), 17–19 h, overhead shaker at
8 rpm and room temperature. Afterward, the carrier was filtered
or separated by centrifugation (4220× g), washed twice with one
volume of Tris buffer (50 mM, pH 7.0) and with one volume
of 0.5 M NaCl solution. Fractions of the supernatant and the
washing steps were collected for further determination of protein
concentration.
Batch Experiments with the Immobilized
Enzyme
For activity analysis, the immobilized enzyme was tested in
batch experiments in 50–100 mL stirred tank reactors for the
conversion of 20 or 25 mM phenylmalonic acid in 45 mM
Tris buffer or in water at pH 7.0 or 8.0 (adjusted with 1 M
NaOH), at 200 rpm and 30◦C. The reaction progress was
monitored by HPLC. Between the batches, the carrier material
was carefully washed with distilled water, filtered or separated by
centrifugation (5 min, 4220× g) and stored at 4◦C until the next
usage.
Recycling Study in Naproxen Malonate
Conversion
The recycling capability of the enzyme was tested for the
conversion of naproxen malonate (110 mM) at pH 8.0. 100 mg
of the amino C2 acrylate carrier with immobilized purified (S)-
selective AMDase-CLGIPL were used in a 2 mL round bottom
microreaction tube (total reaction volume of 1.5 mL). The
reaction was started by the addition of the substrate solution and
conversion was monitored by HPLC. Between the batches, the
carrier was washed with 1 mL of distilled water, separated by
centrifugation (2 min, 12,100 × g) and stored at 4 ◦C until the
next usage.
Investigation of Process Stability of the
Immobilized Enzyme
For stability analysis, 100 mg of amino C2 acrylate carrier
containing the target enzyme was incubated in a round bottom
microreaction tube (2 mL) with a total reaction volume of 1 mL
at 30◦C without substrate and shaken at 900 rpm in water at
pH 8.0 (adjusted with 1 M NaOH) for desired time intervals
(0–600 h). For activity measurements, the immobilized enzyme
was separated by centrifugation (2 min, room temperature,
12,100 × g) and the supernatant was discarded. Afterward, fresh
substrate (1 mL, 25 mM naproxen malonate, pH 8.0) was added
to the immobilized enzyme and the conversion was monitored
by HPLC analysis. After the reaction (72 min for the first activity
analysis, up to 254 min in the last analysis), the carrier was
again separated from the reaction mixture by centrifugation
(2 min, room temperature, 12,100 × g), and the supernatant was
discarded. The carrier was washed with 1 mL of water at pH 8.0
and incubated under the same conditions (1 mL, 900 rpm, pH
8.0, at 30◦C).
Sampling and HPLC Analysis
Samples (500 µL) for the HPLC analysis of the phenylmalonate
conversion were mixed with acetonitrile (250 µL) and transferred
directly into the HPLC vials. For the analysis of naproxen
malonate conversion, samples (12 µL) were collected and
mixed with acetonitrile (6 µL) and diluted 10-fold with
water/acetonitrile (1:1). HPLC analysis was realized with a
C18 reversed phase column (Nucleodur C18 pyramid 250/4.6,
Macherey Nagel) in an Agilent 1100 HPLC system using an
isocratic eluent of ACN:H2O:TFA (59.025:39.025:0.05). The flow
rate of 0.8 mL/min was maintained for 6 min for phenylmalonate
conversion or 9 min for naproxen malonate conversion. The
detection was carried out with a diode array detector at a
wavelength of 245 nm. Typical retention times were: naproxen
5.8 min, naproxen malonate 3.8 min, phenylacetate 4.5 min,
phenylmalonate 3.8 min. Reference chromatograms are available
in the Supplementary Figures S1, S2.
RESULTS AND DISCUSSION
Investigation of the Process stability of
the Free Enzyme
The operational stability is a central aspect for the application
of enzymes in industrial processes. Hence, we first analyzed the
process stability of free wild type AMDase (Figure 2). The result
of the experiment with the purified free wtAMDase reveals a
low process stability with a half-life time (t1/2) of 1.2 h. The
reduction of AMDase activity under thermal incubation over
40◦C has already been analyzed by Miyamoto and Ohta (1992)
who described a 10% loss of activity at 40◦C after 10 min and
a 50% activity loss at 50◦C with 10 min incubation. These data
FIGURE 2 | Relative residual activity of purified free wtAMDase under
process conditions with 2 mg/L wtAMDase, 37.5 mM Tris buffer at pH
7.0, 200 rpm and 30◦C. The specific activities were measured by taking
samples from the incubation mixture and measuring the initial reaction rates
with 20 mM phenylmalonate as substrate.
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indicate an enhanced enzyme inactivation in a temperature range
over 40◦C.
The production of the biocatalyst is an important parameter
for the final cost and environmental footprint of the
arylpropionate synthesis. Therefore, the enzyme stability needs
to be significantly increased in order to reduce the amount of
enzyme needed per unit of product. Immobilization is one of the
most common methods for enzyme stabilization (Bornscheuer,
2003). The possibility of AMDase immobilization had earlier
been demonstrated by using polystyrene nanoparticles, allowing
a recycling of the enzyme up to four times (Wong et al., 2010).
Since we aimed at significantly improving the stability of the
enzyme for profen synthesis, we chose immobilization on a
solid support with larger particle size (∼100–400 µm diameter)
than nanoparticles for an easy separation and straightforward
downstream processing, as described in the next sections.
Screening of Different Carriers for
Immobilization
Screening of solid supports for enzyme immobilization was
carried out with different types of carrier materials with regard
to (i) surface properties, (ii) bonding type, (iii) spacer length,
and (iv) particle size, as these parameters influence the catalytic
performance of the immobilized enzyme (Guisan, 2006). In
total, seven different carriers were evaluated in this first set
of experiments: Amino C2 acrylate, SepabeadsTM EC-EP and
EC-HA, EziGTM 1 and 2 with Co(II) loading, TrisoperlTM and
TrisoperlTM amino. Detailed information on the specification
of the carrier materials are given in Supplementary Table S1
and demonstrate the different characteristic properties each
carrier type has. According to the crystal structure of wild type
AMDase (PDB entry 3IP8, Supplementary Figure S3) (Okrasa
et al., 2009) two lysine resides on the surface of the enzyme
are available for crosslinking with the glutaraldehyde activated
carrier. Alternately, for immobilization via complexation, there
is only one possible immobilization position, the N-terminal
His6-tag (Supplementary Figure S3), which still provides six
amino acids for an efficient immobilization. A comparison of
the effectivity of enzyme immobilization on these distinctly
different carriers and binding modes is therefore highly desirable.
For screening purposes, we first focused our attention on
purified wtAMDase. Phenylmalonate was used as a readily
available model substrate for determining the specific activity
of immobilized enzyme on the different carriers. Measurements
were performed by analyzing the initial reaction rates at up to
5% substrate conversion. Figure 3 shows a comparison of the
carrier materials with respect to enzyme loading and activity of
the immobilized enzyme.
Among the carriers evaluated, the amino C2 acrylate and
Sepabeads EC-HA showed the highest enzyme loadings of
about 80 mgenzyme/gcarrier (Figure 3). This is probably due to
the high density of functional groups on these carriers with
1760 µmol/gcarrier for amino C2 acrylate and >700 µmol/gcarrier
for EC-HA (Supplementary Table S1). The immobilized enzyme
showed activity in the conversion of phenylmalonate on all
tested carrier materials with activities of 2% (amino C2
acrylate, 5.1 U/mgenzyme) to 8% (EziG1 Co(II), 22.6 U/mgenzyme)
compared to the purified free wtAMDase with 282 U/mgenzyme
(Supplementary Figure S4 and Table S2). In respect to the binding
type, the covalently linked enzymes (on carriers of acrylate,
EC-EP and EC-HA) reveal the lowest activities. Nevertheless,
in the case of the acrylate and EC-HA resin only a slight loss
of activity during enzyme recycling was observed. The spacer
FIGURE 3 | Investigation of different carrier materials with respect to enzyme loading (left) and specific enzyme activity in repeated batch
experiments (right) with immobilized purified wtAMDase. Reaction conditions (right): 100 mL reaction volume in stirred tank reactor with overhead stirrer,
200–500 mg carrier material, 20 mM phenylmalonate, 45 mM Tris buffer at pH 7, 200 rpm, and 30◦C. Between the batch experiments, the carrier was filtered and
stored at 4◦C.
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length, which could in principle have a significant influence
on the flexibility and activity of the immobilize enzyme (Cao,
2005), shows no influence on the enzymatic activity (acrylate: C2;
EC-HA: C6). However, stability was slightly enhanced with longer
spacer length (Figure 3). In the repeated batch experiments we
observed for the amino C2 acrylate and EziG1-Co(II) carrier
enhanced specific activities during the second batch. One of
the reasons might be wetting effects. If carriers are not in
contact with the reaction solution beforehand, after the first
batch higher activities can be observed due to the change of
surface polarity. Furthermore, partial substrate adsorption onto
the carriers and consequently an increase of the effective substrate
concentration for the second batch could occur. Using the amino
C2 acrylate and EziG1-Co(II) carriers, 8 and 4% adsorption of
phenylmalonate onto the carrier material was observed, therefore
making this a possible explanation (Supplementary Figure S7).
The highest catalytic performance was found for the enzyme
bound to the porous glass carrier EziGTM Co(II) types 1 and 2
(Figure 3). Here the enzyme is linked by coordination of the His6
tag to cobalt(II) metal ions. Making use of this affinity tag allows
to combine enzyme purification and immobilization in one step
(Engelmark Cassimjee et al., 2014).
Whilst the preliminary immobilization assays were conducted
with wtAMDase, we chose the purified (S)-selective AMDase
mutant (AMDase-CLGIPL) for further analysis, as this variant
allows the synthesis of the desired (S)-arylpropionates with an
excellent enantioselectivity (Gaßmeyer et al., 2016). In a first
set of recyclability experiments, AMDase-CLGIPL activity was
evaluated on different types of porous glass carrier EziGTM.
The carrier materials differ in surface hydrophobicity (type 1:
hydrophilic; 2: hydrophobic; 3: semi-hydrophilic) and in the
coordinating metal ion (Co(II) or Fe(III)).
Analyses were carried out with respect to the enzyme loading
and specific activity (Figure 4). The enzyme loading varied
between 80 and 120 mgenzyme/gcarrier, with the exception of
EziGTM carrier type 1 with Fe(III), which revealed a low loading
of 20 mgenzyme/gcarrier. The enzymatic activity was up to fivefold
higher when immobilized on Fe(III)-based carrier was used
compared to the Co(II)-based EziGTM carrier material. In respect
to the surface properties of the carrier, we observed the best
activity results for enzyme bound to the hydrophilic carrier EziG1
for both coordinating metals. Unfortunately, we also observed
a significant loss of enzymatic activity with all EziGTM carriers
during re-use under the applied reaction conditions. This could
be explained by enzyme leakage through the comparatively
weaker coordinative binding. A second influencing factor for
the observed activity loss might possibly be local pH shifts
inside the porous carrier due to the formation of arylpropionates
from malonic acids. However, overall pH shifts after the batch
experiments were not observed.
Analysis of Enzyme Recycling in
Repetitive Batch Experiments
With the aim to integrate the immobilized enzyme into an
arylpropionate production process, further investigations were
carried out with (S)-selective AMDase-CLGIPL to evaluate
the possibility of enzyme recycling and to demonstrate the
advantages of enzyme immobilization. For this purpose and
based on the above-described results, we now used the amino
C2 acrylate carrier for further experiments as “best candidate”.
In addition, owing to its large particle size (400 µm), its
separation from the reaction solution is straightforward and can
be conducted, e.g., by filtration or centrifugation. Carriers such
FIGURE 4 | Investigation of different types of EziGTM porous glass carrier with respect to enzyme loading (left) and specific enzyme activity in
repeated batch experiments (right) for phenylmalonate conversion catalyzed by immobilized purified (S)-selective AMDase-CLGIPL. Reaction
conditions (right): 50 mL reaction volume, 2 g/L carrier, 45 mM Tris buffer at pH 8.0, 20 mM phenylmalonate, 400 rpm, 30◦C. Between the batch experiments, the
carrier was filtered and stored at 4◦C.
Frontiers in Microbiology | www.frontiersin.org 5 March 2017 | Volume 8 | Article 448
fmicb-08-00448 March 14, 2017 Time: 15:36 # 6
Aßmann et al. Immobilization of Arylmalonate Decarboxylase (AMDase)
FIGURE 5 | Conversion of naproxen malonate catalyzed by
immobilized enzyme. Reaction conditions: 1.5 mL reaction volume,
110 mM naproxen malonate, 66.7 g/L amino C2 acrylate with purified
immobilized (S)-selective AMDase-CLGIPL, enzyme loading:
80.7 mgenzme/gcarrier, 30◦C, 1500 rpm, and pH 8.0.
FIGURE 6 | Comparison of the activities of the (S)-selective
AMDase-CLGIPL immobilized as cell lysate or as purified enzyme.
Reaction conditions: 50 mL reaction volume, 500 rpm, 30◦C, 25 mM
phenylmalonate, 4 g/L amino C2 acrylate carrier with immobilized purified
form or cell lysate form of the (S)-selective AMDase-CLGIPL.
as the significantly smaller Trisoperl material are much more
difficult to remove. The relatively large pore size (120 nm) of
the amino C2 acrylate carrier additionally facilitates the access of
substrate molecules to the immobilized enzyme inside the carrier
FIGURE 7 | Investigation of process stability of immobilized
(S)-selective AMDase-CLGIPL on amino C2 acrylate carrier. Reaction
conditions: 1 mL reaction volume, 100 g/L amino C2 acrylate carrier with
immobilized AMDase mutant, enzyme loading: 23.13 mgenzyme/gcarrier, pH 8,
900 rpm, 30◦C. Activity assay: conversion of 25 mM naproxen malonate. The
carrier was washed after reaction with distilled water and incubated further in
1 mL water at pH 8.0, 30◦C and 900 rpm.
material and may also reduce the chance of local pH “hotspots”
that might result in enzyme inactivation.
For the next set of experiments, we turned our attention
to naproxen malonate as starting material. The decarboxylation
product, naproxen, is of high interest for the pharmaceutical
industry. The enantioselective biosynthesis could be an advantage
to design the process in a more environmentally friendly way.
Due to the good solubility of naproxen malonate disodium
salt (up to 200 mM at pH 8.0), we applied the substrate at
110 mM (30 g/L) in order to achieve high productivity in the
intended process. We further investigated the enzyme’s specific
activity without addition of buffer salts and observed only
a slight shift in the pH and no significant loss of activity.
Accordingly, a continuous back-titration for pH control was
not necessary, which allows considerable savings in reagents
and equipment. While using the immobilized purified AMDase-
CLGIPL (on amino C2 acrylate carrier) full conversion to (S)-
naproxen was achieved in six repetitive batches (Figure 5). The
half-life of the free AMDase-CLGIPL in respect to naproxen
malonate conversion (Supplementary Figure S5) could be
determined as 1.2 h, which is the same value obtained from
the aforementioned experiments with the wild type AMDase
in phenylmalonate conversion (Figure 2). Thus, it states that
the mutations done in the active site of the AMDase and
the type of substrate used do not influence the enzyme’s
process stability. Overall, in a real batch reaction time of
up to 90 h, residual activity of the immobilized AMDase-
CLGIPL enzyme could still be detected (Figure 5). Furthermore,
this experiment demonstrates that the slightly reducing initial
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activities for the repetitive batches do not have a significant effect
on the overall – macroscopic – outcome of the reaction under
process conditions: full conversion can be easily reached even at
prolonged exposition to process conditions.
Optimization of the Immobilization
Procedure by Using Cell Lysate
The efficiency of enzyme preparation is one crucial parameter
for the application of enzymes in a production process. In
this respect, enzyme purification is a major cost and time
consuming factor, leading to fivefold higher production expenses
compared to the application of the enzyme as crude cellular
extract (Tufvesson et al., 2011). Hence, we further focused on the
use of cell lysate instead of purified enzyme for immobilization
strategies. In order to evaluate the usability of the cell lysate,
we immobilized both the purified enzyme and the cell lysate on
amino C2 acrylate carrier and tested their activity (Figure 6).
Our results revealed that per gram of preparation, the
immobilized cell lysate exhibits 30% catalytic activity compared
to the immobilized purified enzyme. When analyzing the amount
of AMDase that is produced during protein expression, it was
found to be about 30% of the total protein amount (determined
based on the activity assay). Thus, the enzymatic activity from
cell lysate coincides with the present AMDase content in
respect to purified enzyme. In addition to that, we observed a
reduced activity loss for immobilized cell lysate in repeated batch
experiments. During four repetitive batches, the specific activity
of the immobilized purified enzyme dropped by ∼70% from 130
to 40 U/gcarrier, whereas the specific activity of immobilized cell
lysate reduced 40% from 42 to 25 U/gcarrier. AMDase seems to be
more stable in a co-immobilized form with surrounding proteins
from the cell lysate. This might be explained by a stabilizing
effect caused by altered enzyme surface properties in presence
of endogenous proteins from the cell lysate. This stabilizing
effect of foreign proteins in the immobilization process is in
some cases used to produce more stable enzyme preparations,
for example by co-immobilization of helper proteins, like bovine
serum albumin (BSA), in the production of cross-linked enzyme
aggregates (CLEAs) (Ahumada et al., 2015).
Investigation of the Process Stability of
the Immobilized Cell Lysate
In the last set of experiments, we evaluated the long-term
operational stability of immobilized cell lysate on the amino
C2 acrylate carrier. For this purpose, we incubated the enzyme
formulation under process conditions at 30◦C while shaking and
measured residual enzyme activities by HPLC. We observed a
half-life time of about 8.6 days (Figure 7), which corresponds to a
158-fold higher stability of immobilized AMDase-containing cell
lysate compared to the free enzyme with a half-life time of only
1.2 h (determined for the wild type enzyme for phenylmalonate
as substrate).
CONCLUSION
In this study we successfully demonstrated the stabilization of
AMDase by evaluating different solid supports with diverse
characteristics. Next to the enzyme immobilization, we focused
our attention on the optimization of the enzymatic process by
eliminating the use of buffer salts as well as the purification
step, which saves reagents and equipment. By these means, the
(S)-selective AMDase-CLGIPL mutant is now qualified for a
highly productive synthesis of arylpropionates. Our follow-up
experiments will focus on the scaling-up of naproxen synthesis
using the highly enantioselective (ee> 99%) (S)-AMDase variant.
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